A Note On Skyward Specialty Insurance Group, Inc.'s (NASDAQ:SKWD) ROE and Debt To Equity
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business.
Skyward Spec Insurance Is Maintained at Market Outperform by JMP Securities
Skyward Spec Insurance Is Maintained at Market Outperform by JMP Securities
J.P. Morgan Securities: Maintaining the Skyward Specialty (SKWD.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $40.00 to $42.00.
J.P. Morgan Securities: Maintaining the Skyward Specialty (SKWD.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $40.00 to $42.00.
JMP Securities Maintains Market Outperform on Skyward Specialty, Raises Price Target to $42
JMP Securities analyst Matthew Carletti maintains Skyward Specialty (NASDAQ:SKWD) with a Market Outperform and raises the price target from $40 to $42.
Will Skyward (SKWD) Beat Estimates Again in Its Next Earnings Report?
Skyward Specialty Is Maintained at Outperform by Keefe, Bruyette & Woods
Skyward Specialty Is Maintained at Outperform by Keefe, Bruyette & Woods
Are You Looking for a Top Momentum Pick? Why Skyward Specialty Insurance (SKWD) Is a Great Choice
Keefe, Bruyette & Woods Maintains Outperform on Skyward Specialty, Raises Price Target to $44
Keefe, Bruyette & Woods analyst Meyer Shields maintains Skyward Specialty with a Outperform and raises the price target from $43 to $44.
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
Skyward Specialty to Host First Quarter 2024 Earnings Call Thursday, May 2, 2024
Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) expects to issue its first quarter 2024 earnings results after the market closes on Wednesday, May 1, which will be available on the Company website at investors.skywardinsurance.com/ under Quarterly Results.
Keefe, Bruyette & Woods Maintains Outperform on Skyward Specialty, Maintains $43 Price Target
Keefe, Bruyette & Woods analyst Meyer Shields maintains Skyward Specialty (NASDAQ:SKWD) with a Outperform and maintains $43 price target.
Analysts Offer Insights on Financial Companies: Skyward Specialty Insurance Group, Inc. (SKWD) and CME Group (CME)
Analyst Expectations For Skyward Specialty's Future
In the preceding three months, 7 analysts have released ratings for Skyward Specialty (NASDAQ:SKWD), presenting a wide array of perspectives from bullish to bearish.Summarizing their recent assessment
Skyward Specialty Price Target Raised to $46.00/Share From $43.00 by Piper Sandler
Skyward Specialty Price Target Raised to $46.00/Share From $43.00 by Piper Sandler
Skyward Specialty Is Maintained at Overweight by Piper Sandler
Skyward Specialty Is Maintained at Overweight by Piper Sandler
Skyward Specialty Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/01/2024 22.68% Piper Sandler $43 → $46 Maintains Overweight 02/26/2024 -1.32% BMO Capital $31 → $37 Mai
Skyward Specialty Insurance Group, Inc. (SKWD) Receives a Buy From Piper Sandler
Investors Interested In Skyward Specialty Insurance Group, Inc.'s (NASDAQ:SKWD) Earnings
It's not a stretch to say that Skyward Specialty Insurance Group, Inc.'s (NASDAQ:SKWD) price-to-earnings (or "P/E") ratio of 17.7x right now seems quite "middle-of-the-road" compared to the market in
Skyward Specialty and New Heights Partner to Broaden Crane and Rigging Products, Offerings
HOUSTON, March 26, 2024 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) ("Skyward Specialty") a leader in the specialty property and casualty market, and New Heights Insur
Skyward Specialty Insurance(SKWD.US) Officer Sells US$989.44K in Common Stocks
$Skyward Specialty Insurance(SKWD.US)$ Officer Robinson Andrew S sold 27,650 shares of Common Stocks on Mar 11, 12, 2024 at an average price of $35.78 for a total value of $989.44K.Source: Announcemen
No Data